• Je něco špatně v tomto záznamu ?

Impact of Multiple Sclerosis Subtypes on Pain Management in Patients With Trigeminal Neuralgia After Stereotactic Radiosurgery: An International Multicenter Analysis

F. De Nigris Vasconcellos, E. Mashiach, JD. Alzate, K. Bernstein, L. Rotman, S. Levy, T. Qu, RE. Wegner, MJ. Shepard, S. Patel, RE. Warnick, NM. Moreno, R. Martínez Álvarez, P. Picozzi, A. Franzini, S. Peker, Y. Samanci, AN. Elguindy, JD. Palmer,...

. 2024 ; 94 (4) : 838-846. [pub] 20231205

Jazyk angličtina Země Spojené státy americké

Typ dokumentu multicentrická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006609

BACKGROUND AND OBJECTIVES: Trigeminal neuralgia affects approximately 2% of patients with multiple sclerosis (MS) and often shows higher rates of pain recurrence after treatment. Previous studies on the effectiveness of stereotactic radiosurgery (SRS) for trigeminal neuralgia did not consider the different MS subtypes, including remitting relapsing (RRMS), primary progressive (PPMS), and secondary progressive (SPMS). Our objective was to investigate how MS subtypes are related to pain control (PC) rates after SRS. METHODS: We conducted a retrospective multicenter analysis of prospectively collected databases. Pain status was assessed using the Barrow National Institute Pain Intensity Scales. Time to recurrence was estimated through the Kaplan-Meier method and compared groups using log-rank tests. Logistic regression was used to calculate the odds ratio (OR). RESULTS: Two hundred and fifty-eight patients, 135 (52.4%) RRMS, 30 (11.6%) PPMS, and 93 (36%) SPMS, were included from 14 institutions. In total, 84.6% of patients achieved initial pain relief, with a median time of 1 month; 78.7% had some degree of pain recurrence with a median time of 10.2 months for RRMS, 8 months for PPMS, 8.1 months for SPMS ( P = .424). Achieving Barrow National Institute-I after SRS was a predictor for longer periods without recurrence ( P = .028). Analyzing PC at the last available follow-up and comparing with RRMS, PPMS was less likely to have PC (OR = 0.389; 95% CI 0.153-0.986; P = .047) and SPMS was more likely (OR = 2.0; 95% CI 0.967-4.136; P = .062). A subgroup of 149 patients did not have other procedures apart from SRS. The median times to recurrence in this group were 11.1, 9.8, and 19.6 months for RRMS, PPMS, and SPMS, respectively (log-rank, P = .045). CONCLUSION: This study is the first to investigate the relationship between MS subtypes and PC after SRS, and our results provide preliminary evidence that subtypes may influence pain outcomes, with PPMS posing the greatest challenge to pain management.

Department of Neurological Surgery NYU Langone Health New York University New York New York USA

Department of Neurological Surgery UPMC Pittsburgh Pennsylvania USA

Department of Neurology Mount Sinai Corinne Goldsmith Dickinson Center for MS Mount Sinai New York USA

Department of Neurosurgery Allegheny Health Network Pittsburgh Pennsylvania USA

Department of Neurosurgery Centre de recherche du CHUS Université de Sherbrooke Sherbrooke Canada

Department of Neurosurgery Gamma Knife Center Jewish Hospital Mayfield Clinic Cincinnati Ohio USA

Department of Neurosurgery IRCCS Humanitas Research Hospital Rozzano Italy

Department of Neurosurgery Koc University School of Medicine Istanbul Turkey

Department of Neurosurgery North Shore University Hospital Hempstead New York USA

Department of Neurosurgery North Shore University Hospital Manhasset New York USA

Department of Neurosurgery North Shore University Hospital SUNY Downstate College of Medicine Brooklyn New York USA

Department of Neurosurgery University of Southern California Los Angeles California USA

Department of Neurosurgery UVA Charlottesville Virginia USA

Department of Radiation Oncology NYU Langone Health New York University New York New York USA

Department of Radiation Oncology The James Cancer Hospital at The Ohio State University Columbus Ohio USA

Division of Radiation Oncology Allegheny Health Network Cancer Institute Allegheny Health Network Pittsburgh Pennsylvania USA

Division of Radiation Oncology Department of Oncology University of Alberta Edmonton Canada

Radiosurgery Unit Hospital Ruber Internacional Madrid Spain

Stereotactic and Radiation Neurosurgery Na Homolce Hospital Prague Czechia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006609
003      
CZ-PrNML
005      
20240423155409.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1227/neu.0000000000002790 $2 doi
035    __
$a (PubMed)38051068
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a De Nigris Vasconcellos, Fernando $u Department of Neurological Surgery, NYU Langone Health, New York University, New York , New York , USA $1 https://orcid.org/0000000298490049
245    10
$a Impact of Multiple Sclerosis Subtypes on Pain Management in Patients With Trigeminal Neuralgia After Stereotactic Radiosurgery: An International Multicenter Analysis / $c F. De Nigris Vasconcellos, E. Mashiach, JD. Alzate, K. Bernstein, L. Rotman, S. Levy, T. Qu, RE. Wegner, MJ. Shepard, S. Patel, RE. Warnick, NM. Moreno, R. Martínez Álvarez, P. Picozzi, A. Franzini, S. Peker, Y. Samanci, AN. Elguindy, JD. Palmer, LD. Lunsford, SG. Jose, Z. Wei, A. Niranjan, S. Blagui, C. Iorio-Morin, D. Mathieu, RG. Briggs, C. Yu, G. Zada, S. Dayawansa, J. Sheehan, M. Schulder, A. Goenka, S. Begley, H. Khilji, D. Urgošík, R. Liščák, D. Kondziolka
520    9_
$a BACKGROUND AND OBJECTIVES: Trigeminal neuralgia affects approximately 2% of patients with multiple sclerosis (MS) and often shows higher rates of pain recurrence after treatment. Previous studies on the effectiveness of stereotactic radiosurgery (SRS) for trigeminal neuralgia did not consider the different MS subtypes, including remitting relapsing (RRMS), primary progressive (PPMS), and secondary progressive (SPMS). Our objective was to investigate how MS subtypes are related to pain control (PC) rates after SRS. METHODS: We conducted a retrospective multicenter analysis of prospectively collected databases. Pain status was assessed using the Barrow National Institute Pain Intensity Scales. Time to recurrence was estimated through the Kaplan-Meier method and compared groups using log-rank tests. Logistic regression was used to calculate the odds ratio (OR). RESULTS: Two hundred and fifty-eight patients, 135 (52.4%) RRMS, 30 (11.6%) PPMS, and 93 (36%) SPMS, were included from 14 institutions. In total, 84.6% of patients achieved initial pain relief, with a median time of 1 month; 78.7% had some degree of pain recurrence with a median time of 10.2 months for RRMS, 8 months for PPMS, 8.1 months for SPMS ( P = .424). Achieving Barrow National Institute-I after SRS was a predictor for longer periods without recurrence ( P = .028). Analyzing PC at the last available follow-up and comparing with RRMS, PPMS was less likely to have PC (OR = 0.389; 95% CI 0.153-0.986; P = .047) and SPMS was more likely (OR = 2.0; 95% CI 0.967-4.136; P = .062). A subgroup of 149 patients did not have other procedures apart from SRS. The median times to recurrence in this group were 11.1, 9.8, and 19.6 months for RRMS, PPMS, and SPMS, respectively (log-rank, P = .045). CONCLUSION: This study is the first to investigate the relationship between MS subtypes and PC after SRS, and our results provide preliminary evidence that subtypes may influence pain outcomes, with PPMS posing the greatest challenge to pain management.
650    _2
$a lidé $7 D006801
650    12
$a neuralgie trigeminu $x radioterapie $x chirurgie $7 D014277
650    _2
$a výsledek terapie $7 D016896
650    _2
$a management bolesti $x metody $7 D059408
650    12
$a radiochirurgie $x metody $7 D016634
650    12
$a roztroušená skleróza $x chirurgie $7 D009103
650    _2
$a lokální recidiva nádoru $x chirurgie $7 D009364
650    _2
$a bolest $x etiologie $x chirurgie $7 D010146
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mashiach, Elad $u Department of Neurological Surgery, NYU Langone Health, New York University, New York , New York , USA
700    1_
$a Alzate, Juan Diego $u Department of Neurological Surgery, NYU Langone Health, New York University, New York , New York , USA
700    1_
$a Bernstein, Kenneth $u Department of Radiation Oncology, NYU Langone Health, New York University, New York , New York , USA
700    1_
$a Rotman, Lauren $u Department of Neurological Surgery, NYU Langone Health, New York University, New York , New York , USA
700    1_
$a Levy, Sarah $u Department of Neurology, Mount Sinai Corinne Goldsmith Dickinson Center for MS, Mount Sinai , New York , USA
700    1_
$a Qu, Tanxia $u Department of Radiation Oncology, NYU Langone Health, New York University, New York , New York , USA
700    1_
$a Wegner, Rodney E $u Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh , Pennsylvania , USA
700    1_
$a Shepard, Matthew J $u Department of Neurosurgery, Allegheny Health Network, Pittsburgh , Pennsylvania , USA
700    1_
$a Patel, Samir $u Division of Radiation Oncology, Department of Oncology, University of Alberta, Edmonton , Canada
700    1_
$a Warnick, Ronald E $u Department of Neurosurgery, Gamma Knife Center, Jewish Hospital, Mayfield Clinic, Cincinnati , Ohio , USA
700    1_
$a Moreno, Nuria Martínez $u Radiosurgery Unit, Hospital Ruber Internacional, Madrid , Spain
700    1_
$a Martínez Álvarez, Roberto $u Radiosurgery Unit, Hospital Ruber Internacional, Madrid , Spain
700    1_
$a Picozzi, Piero $u Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano , Italy
700    1_
$a Franzini, Andrea $u Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano , Italy
700    1_
$a Peker, Selçuk $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey
700    1_
$a Samanci, Yavuz $u Department of Neurosurgery, Koc University School of Medicine, Istanbul , Turkey
700    1_
$a Elguindy, Ahmed N $u Department of Radiation Oncology, The James Cancer Hospital at The Ohio State University, Columbus , Ohio , USA
700    1_
$a Palmer, Joshua D $u Department of Radiation Oncology, The James Cancer Hospital at The Ohio State University, Columbus , Ohio , USA
700    1_
$a Lunsford, L Dade $u Department of Neurological Surgery, UPMC, Pittsburgh , Pennsylvania , USA
700    1_
$a Jose, Shalini G $u Department of Neurological Surgery, UPMC, Pittsburgh , Pennsylvania , USA
700    1_
$a Wei, Zhishuo $u Department of Neurological Surgery, UPMC, Pittsburgh , Pennsylvania , USA
700    1_
$a Niranjan, Ajay $u Department of Neurological Surgery, UPMC, Pittsburgh , Pennsylvania , USA
700    1_
$a Blagui, Sarra $u Department of Neurosurgery, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke , Canada
700    1_
$a Iorio-Morin, Christian $u Department of Neurosurgery, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke , Canada
700    1_
$a Mathieu, David $u Department of Neurosurgery, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke , Canada
700    1_
$a Briggs, Robert G $u Department of Neurosurgery, University of Southern California, Los Angeles , California , USA
700    1_
$a Yu, Cheng $u Department of Neurosurgery, University of Southern California, Los Angeles , California , USA
700    1_
$a Zada, Gabriel $u Department of Neurosurgery, University of Southern California, Los Angeles , California , USA
700    1_
$a Dayawansa, Samantha $u Department of Neurosurgery, UVA, Charlottesville , Virginia , USA
700    1_
$a Sheehan, Jason $u Department of Neurosurgery, UVA, Charlottesville , Virginia , USA
700    1_
$a Schulder, Michael $u Department of Neurosurgery, North Shore University Hospital (Northwell), Manhasset , New York , USA
700    1_
$a Goenka, Anuj $u Department of Neurosurgery, North Shore University Hospital (Northwell), Manhasset , New York , USA
700    1_
$a Begley, Sabrina $u Department of Neurosurgery, North Shore University Hospital (Northwell Zucker School of Medicine), Hempstead , New York , USA
700    1_
$a Khilji, Hamza $u Department of Neurosurgery, North Shore University Hospital, SUNY Downstate College of Medicine, Brooklyn , New York , USA
700    1_
$a Urgošík, Dušan $u Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague , Czechia
700    1_
$a Liščák, Roman $u Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague , Czechia
700    1_
$a Kondziolka, Douglas $u Department of Neurological Surgery, NYU Langone Health, New York University, New York , New York , USA
773    0_
$w MED00003511 $t Neurosurgery $x 1524-4040 $g Roč. 94, č. 4 (2024), s. 838-846
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38051068 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155405 $b ABA008
999    __
$a ok $b bmc $g 2080924 $s 1216376
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 94 $c 4 $d 838-846 $e 20231205 $i 1524-4040 $m Neurosurgery $n Neurosurgery $x MED00003511
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...